海辰药业
(300584)
| 流通市值：14.80亿 | | | 总市值：21.62亿 |
| 流通股本：8211.86万 | | | 总股本：1.20亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 104,561,855.22 | 517,832,192 | 377,948,363.64 | 261,547,849.93 |
| 营业收入 | 104,561,855.22 | 517,832,192 | 377,948,363.64 | 261,547,849.93 |
| 二、营业总成本 | 85,582,384.45 | 475,390,505.12 | 350,261,784.04 | 237,466,136.47 |
| 营业成本 | 18,677,772.39 | 96,594,643.93 | 69,138,496.49 | 45,231,823.1 |
| 税金及附加 | 2,415,960.22 | 11,292,529.73 | 8,385,143.3 | 5,693,449.55 |
| 销售费用 | 38,595,773.27 | 241,595,638.54 | 180,025,425.29 | 123,271,654.45 |
| 管理费用 | 18,419,917.88 | 71,915,662.18 | 55,857,864.14 | 36,736,625.89 |
| 研发费用 | 5,429,812.44 | 46,634,035.48 | 31,900,346.61 | 23,377,177.13 |
| 财务费用 | 2,043,148.25 | 7,357,995.26 | 4,954,508.2 | 3,155,406.36 |
| 其中:利息费用 | 2,071,727.45 | 8,272,643.27 | 6,620,282.55 | 3,810,890.65 |
| 其中:利息收入 | 44,881.08 | 960,836.68 | 854,063.94 | 658,395.67 |
| 加:公允价值变动收益 | - | 64,178.97 | 62,369.72 | 58,520.67 |
| 加:投资收益 | -105 | -24,372.12 | - | - |
| 资产处置收益 | - | -791,829.47 | 343,411.59 | 343,411.59 |
| 资产减值损失(新) | -3,118,633.22 | -4,681,304.37 | -6,188,489.8 | -4,603,144.71 |
| 信用减值损失(新) | 206,023.07 | -1,676,994.6 | 327,989.18 | 123,274.57 |
| 其他收益 | 268,517.26 | 3,961,183.25 | 1,856,133.52 | 1,171,918.5 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 16,335,272.88 | 39,292,548.54 | 24,087,993.81 | 21,175,694.08 |
| 加:营业外收入 | 150.2 | 239,830.43 | 231,258.36 | 240,384.9 |
| 减:营业外支出 | 62,150.32 | 1,843,095.43 | 1,356,920.68 | 1,120,320.07 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 16,273,272.76 | 37,689,283.54 | 22,962,331.49 | 20,295,758.91 |
| 减:所得税费用 | 2,915,459.32 | 1,373,729.47 | 539,899.03 | 820,832.39 |
| 六、净利润 | 13,357,813.44 | 36,315,554.07 | 22,422,432.46 | 19,474,926.52 |
| 持续经营净利润 | 13,357,813.44 | 36,315,554.07 | 22,422,432.46 | 19,474,926.52 |
| 归属于母公司股东的净利润 | 13,357,813.44 | 36,315,554.07 | 22,422,432.46 | 19,474,926.52 |
| (一)基本每股收益 | 0.11 | 0.3 | 0.19 | 0.16 |
| (二)稀释每股收益 | 0.11 | 0.3 | 0.19 | 0.16 |
| 九、综合收益总额 | 13,357,813.44 | 36,315,554.07 | 22,422,432.46 | 19,474,926.52 |
| 归属于母公司股东的综合收益总额 | 13,357,813.44 | 36,315,554.07 | 22,422,432.46 | 19,474,926.52 |
| 公告日期 | 2024-04-25 | 2024-04-25 | 2023-10-27 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |